Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study

American Journal of Medicine

Volumn 109, Issue 1, 2000, Pages 1-8

  Culleton, Bruce F ^a   Larson, Martin G ^a,b   Parfrey, Patrick S ^c   Kannel, William B ^a,b   Levy, Daniel ^a,b  

^a Blood Inst's F   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; URINALYSIS;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MASSACHUSETTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0034725723     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00444-7     Document Type: Article

References (57)

1. Ruggenenti P., Perna A., Mosconi L., et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int. 53:1998;1209-1216.
2. Abbott K.C., Sanders L.R., Bakris G.L. Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival. Arch Intern Med. 154:1994;146-153.
3. Miettinen H., Haffner S.M., Lehto S., et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 27:1996;2033-2039.
4. Wagner D.K., Harris T., Madans J.H. Proteinuria as a biomarker risk of subsequent morbidity and mortality . Environ Res. 66:1994;160-172.
5. Samuelsson O., Wilhelmsen L., Elmfeldt D., et al. Predictors of cardiovascular morbidity in treated hypertension results from the primary preventive trial in Goteborg, Sweden . J Hypertens. 3:1985;167-176.
6. Ljungman S., Wikstrand J., Hartford M., Berglund G. Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens. 9:1996;770-778.
7. Morrish N.J., Stevens L.K., Fuller J.H., et al. Risk factors for macrovascular disease in diabetes mellitus the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics . Diabetologia. 34:1991;590-594.
8. Messent J.W., Elliott T.G., Hill R.D., et al. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus a twenty-three year follow-up study . Kidney Int. 41:1992;836-839.
9. Schmitz A., Vaeth M. Microalbuminuria a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients . Diabet Med. 5:1988;126-134.
10. Gall M.A., Borch-Johnsen K., Hougaard P., et al. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 44:1995;1303-1309.
11. Agewall S., Wikstrand J., Ljungman S., Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk factor intervention study group. Am J Cardiol. 80:1997;164-169.
12. Grimm R.H. Jr, Svendsen K.H., Kasiske B., et al. Proteinuria is a risk factor for mortality over 10 years of follow-up. Kidney Int. 52:(suppl):1997;10-14.
13. Kannel W.B., Stampfer M.J., Castelli W.P., Verter J. The prognostic significance of proteinuria the Framingham study . Am Heart J. 108:1984;1347-1352.
14. Casiglia E., Pauletto P., Mazza A., et al. Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects. Ten-year mortality and morbidity in the CASTEL study. Acta Diabetol. 33:1996;284-290.
15. Stephenson J.M., Kenny S., Stevens L.K., et al. Proteinuria and mortality in diabetes the WHO multinational study of vascular disease in diabetes . Diabet Med. 12:1995;149-155.
16. Mattock M.B., Morrish N.J., Viberti G., et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
17. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int. 41:1992;731-735.
18. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. NEJM. 310:1984;356-360.
19. Nelson R.G., Pettitt D.J., Carraher M.J., et al. Effect of proteinuria on mortality in NIDDM. Diabetes. 37:1988;1499-1504.
20. Jarrett R.J., Viberti G.C., Argyropoulos A., et al. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med. 1:1984;17-19.
21. Neil A., Hawkins M., Potok M., et al. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 16:1993;996-1003.
22. Bulpitt C.J., Beilin L.J., Clifton P., et al. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet. 2:1979;134-137.
23. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 300:1990;297-300.
24. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 32:1989;219-226.
25. Bianchi S., Bigazzi R., Valtriani C., et al. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 23:1994;681-687.
26. Haffner S.M., Stern M.P., Gruber M.K., et al. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis. 10:1990;727-731.
27. Groop L., Ekstrand A., Forsblom C., et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;642-647.
28. Woo J., Cockram C.S., Swaminathan R., et al. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol. 37:1992;345-350.
29. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects the insulin resistance atherosclerosis study . Diabetes. 47:1998;793-800.
30. Hoogeveen E.K., Kostense P.J., Jager A., et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria the Hoorn study . Kidney Int. 54:1998;203-209.
31. Chico A., Perez A., Cordoba A., et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 41:1998;684-693.
32. Bigazzi R., Bianchi S., Nenci R., et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens. 9:1995;827-833.
33. Knobl P., Schernthaner G., Schnack C., et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:1993;1045-1050.
34. Harris T., Cook E.F., Kannel W.B., Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older the Framingham Heart Study . J Am Geriatr Soc. 36:1988;1023-1028.
35. Dawber T.R., Meadors G.F., Moore F.E. Epidemiologic approaches to heart disease the Framingham Heart Study . Am J Public Health. 41:1951;279-286.
36. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
37. Abell L.L., Levy B.B., Brodie B.B., Kendall F.E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 195:1952;357-366.
38. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Heart Study 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study, Section 30. Washington, DC: US Government Printing Office; 1974:7-25.
39. Cox D.R. Regression models and life tables. J Roy Stat Soc. 34:1972;187-220.
40. SAS/STAT User's Guide, Version 6. 1989;SAS Institute, Cary, NC.
41. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. 2:1988;530-533.
42. Damsgaard E.M., Froland A., Jorgensen O.D., Morgensen C.E. Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment. Diabetologia. 36:1993;1030-1036.
43. Bigazzi R., Bianchi S., Baldari D., Campese V.M. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 16:1998;1325-1333.
44. Stehouwer C.D., Nauta J.J., Zeldenrust G.C., et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 340:1992;319-323.
45. Jensen J.S., Borch-Johnsen K., Jensen G., Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch). 88:1995;629-633.
46. Pedrinelli R., Giampietro O., Carmassi F., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344:1994;14-18.
47. Fleck A., Raines G., Hawker F., et al. Increased vascular permeability a major cause of hypoalbuminaemia in disease and injury . Lancet. 1:1985;781-784.
48. Nelson R.G., Knowler W.C., Pettitt D.J., et al. Diabetic kidney disease in Pima Indians. Diabetes Care. 16:1993;335-341.
49. Brancati F.L., Whittle J.C., Whelton P.K., et al. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 268:1992;3079-3084.
50. Smith S.R., Svetkey L.P., Dennis V.W. Racial differences in the incidence and progression of renal diseases. Kidney Int. 40:1991;815-822.
51. Whittle J.C., Whelton P.K., Seidler A.J., Klag M.J. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med. 151:1991;1359-1364.
52. Schwab S.J., Dunn F.L., Feinglos M.N. Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care. 15:1992;1581-1584.
53. Robinson R.R. Isolated proteinuria in asymptomatic patients. Kidney Int. 18:1980;395-406.
54. Poortmans J.R. Postexercise proteinuria in humans. Facts and mechanisms. JAMA. 253:1985;236-240.
55. Poortmans J.R., Brauman H., Staroukine M., et al. Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol. 254:1988;277-283.
56. Carrie B.J., Hilberman M., Schroeder J.S., Myers B.D. Albuminuria and the permselective properties of the glomerulus in cardiac failure. Kidney Int. 17:1980;507-514.
57. Rytand D.A., Spreiter S. Prognosis in postural (orthostatic) proteinuria forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis . NEJM. 305:1981;618-621.